Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@UlmHi 7
@bulletin_en 7
@WeekHerald 6
@mmahotstuff1 6
@ThisLincolnian 6

Recent Tweets for CBAY

ThisLincolnian @ThisLincolnian
CymaBay Therapeutics $CBAY Downgraded by BidaskClub to Hold https://t.co/4nzbFIiFSm
April 19th 2019, 12:04pm
mmahotstuff1 @mmahotstuff1
Is Cymabay Therapeutics $CBAY Now a Sell? How Analysts Rate it and Why BidaskScore Downgraded The Stock https://t.co/vOSRzDrkXx
April 19th 2019, 12:04am
whatsonthorold2 @whatsonthorold2
Will Today’s BidaskScore Downgrade Harm Cymabay Therapeutics $CBAY Stock? https://t.co/aMogNxW2O5
April 19th 2019, 12:04am
bibeypost_stock @bibeypost_stock
Cymabay Therapeutics $CBAY Seems to Be a Stock That BidaskScore Is a Bit Wary of; Firm Downgrades Shares https://t.co/0E1Eix86X9
April 19th 2019, 12:04am
reurope_stock @reurope_stock
Time To Sell Cymabay Therapeutics $CBAY? BidaskScore Downgrades Shares Today https://t.co/2I8II0AB1U
April 19th 2019, 12:04am
UlmHi @UlmHi
Comparing of Outlook Therapeutics Inc. $CBAY https://t.co/kyUSt2xl7n
April 19th 2019, 12:04am
bulletin_en @bulletin_en
Comparison of Homology Medicines Inc. $CBAY https://t.co/LNcaACAc37
April 18th 2019, 9:04pm
W170Ro @W170Ro
$cbay covering my $icpt short and adding more cbay.
April 18th 2019, 12:04pm
stocknewstimes @stocknewstimes
CymaBay Therapeutics $CBAY Given a $20.00 Price Target at Cantor Fitzgerald https://t.co/ZIr1ejDA9D
April 18th 2019, 2:04am
TheMarketsDaily @TheMarketsDaily
Oppenheimer Analysts Give CymaBay Therapeutics $CBAY a $18.00 Price Target https://t.co/NmHPKnAxnd
April 18th 2019, 2:04am
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Given a $20.00 Price Target at Cantor Fitzgerald https://t.co/iwRVyfYrBf
April 18th 2019, 2:04am
macondailynews @macondailynews
Oppenheimer Analysts Give CymaBay Therapeutics $CBAY a $18.00 Price Target https://t.co/yAtAm2nEuR
April 18th 2019, 2:04am
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY Cut to “Hold” at BidaskClub https://t.co/Bh3FPYM5fd
April 18th 2019, 1:04am
UlmHi @UlmHi
Insmed Incorporated $CBAY Comparison side by side https://t.co/oprFawtPK2
April 18th 2019, 1:04am
UlmHi @UlmHi
As Annaly Cap Mgmt $NLY Stock Rose, Jd Capital Management Cut Holding; As Cymabay $CBAY Share Price Rose, Sharehold… https://t.co/6r8ZjxRPjr
April 17th 2019, 2:04pm
W170Ro @W170Ro
$cbay continue to add below 12, NASH Phase 2B 12 week data due early May
April 17th 2019, 1:04pm
UlmHi @UlmHi
Blackstone Group LP $BX Valuation Declined While Martin Currie LTD Upped Stake; As Cymabay Therapeutics $CBAY Marke… https://t.co/mj0lNWkKG2
April 17th 2019, 11:04am
bulletin_en @bulletin_en
As Cymabay Therapeutics $CBAY Stock Price Rose, Shareholder Perceptive Advisors Decreased Position by $1.96 Million… https://t.co/j0vrbv21OS
April 17th 2019, 5:04am
thefinreviewer @thefinreviewer
Abingworth Llp Cut Cymabay $CBAY Position as Share Price Rose; As Tjx Cos New $TJX Share Price Rose, Cabot Wealth M… https://t.co/o2YDvPnO7d
April 17th 2019, 5:04am
TranscriptDaily @TranscriptDaily
Oppenheimer Analysts Give CymaBay Therapeutics $CBAY a $18.00 Price Target https://t.co/7JhvjB7O8b
April 17th 2019, 4:04am
newswithvalue @newswithvalue
$CBAY: CymaBay Therapeutics (NASDAQ:CBAY) Shareholders Have …: https://t.co/KDb7SyKLtq
April 16th 2019, 3:04pm
bibeypost_stock @bibeypost_stock
It's been a crucial week for CymaBay Therapeutics, Inc. $CBAY; here's what analysts have to say. https://t.co/McSkuGwDUC
April 16th 2019, 2:04pm
mmahotstuff1 @mmahotstuff1
Is Buying CymaBay Therapeutics, Inc. $CBAY Here a Winning Strategy? https://t.co/VoLCdMmbzC
April 16th 2019, 2:04pm
BlogYomi @BlogYomi
Cymabay $CBAY Shareholder Abingworth Llp Trimmed Holding; St Joe Co $JOE Shareholder Fairholme Capital Management H… https://t.co/2AGPHDx2nV
April 16th 2019, 8:04am
mmahotstuff1 @mmahotstuff1
$-0.35 EPS Expected for CymaBay Therapeutics, Inc. $CBAY https://t.co/HEEJbNt5RV
April 16th 2019, 1:04am
bibeypost_stock @bibeypost_stock
CymaBay Therapeutics, Inc. $CBAY EPS Estimated At $-0.35 https://t.co/UxxDDmlhQX
April 16th 2019, 1:04am
reurope_stock @reurope_stock
Analysts See $-0.35 EPS for CymaBay Therapeutics, Inc. $CBAY https://t.co/NoXAanHj3C
April 16th 2019, 1:04am
ConsumerFeed @ConsumerFeed
CymaBay Therapeutics $CBAY PT Set at $18.00 by Oppenheimer https://t.co/lvmsN1o5Vw
April 16th 2019, 1:04am
bbnsnews @bbnsnews
CymaBay Therapeutics $CBAY PT Set at $20.00 by Cantor Fitzgerald https://t.co/IJpljmAfE7
April 16th 2019, 1:04am
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY PT Set at $20.00 by Cantor Fitzgerald https://t.co/zjx7a7IYbd
April 16th 2019, 1:04am
OlympiaReport @OlympiaReport
CymaBay Therapeutics $CBAY Given a $20.00 Price Target by Cantor Fitzgerald Analysts https://t.co/PNyXLxj0gP
April 15th 2019, 7:04am
WeekHerald @WeekHerald
CymaBay Therapeutics $CBAY Given a $18.00 Price Target by Oppenheimer Analysts https://t.co/lLKEWcnXah
April 15th 2019, 7:04am
ThisLincolnian @ThisLincolnian
CymaBay Therapeutics $CBAY Given a $18.00 Price Target by Oppenheimer Analysts https://t.co/0hJA9qevQZ
April 15th 2019, 6:04am
TickerReport @TickerReport
CymaBay Therapeutics $CBAY Downgraded by ValuEngine https://t.co/dwwYarTqzs
April 15th 2019, 4:04am
ConsumerFeed @ConsumerFeed
BidaskClub Downgrades CymaBay Therapeutics $CBAY to Buy https://t.co/WTpg4PemWC
April 15th 2019, 4:04am
bulletin_en @bulletin_en
Anticipated $-0.35 EPS for CymaBay Therapeutics, Inc. $CBAY as of May, 14 https://t.co/V4fTvfPH2k
April 15th 2019, 1:04am
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $CBAY is $21.7 https://t.co/QLXbsboNw8
April 14th 2019, 11:04pm
UlmHi @UlmHi
22nd Century Group Inc. $CBAY Comparison side by side https://t.co/7pf2yEFQha
April 14th 2019, 10:04pm
1MinuteStock @1MinuteStock
Wondering about risks of $CBAY? The 21-day volatility is 12.83% https://t.co/xTcLC6uhlN
April 14th 2019, 10:04pm
AmericanBanking @AmericanBanking
CymaBay Therapeutics $CBAY Given a $18.00 Price Target by Oppenheimer Analysts https://t.co/STQQP87MV2 #stocks
April 14th 2019, 9:04pm
AmericanBanking @AmericanBanking
Cantor Fitzgerald Reiterates $20.00 Price Target for CymaBay Therapeutics $CBAY https://t.co/PHGsHxcYvt #stocks
April 14th 2019, 9:04pm
WeekHerald @WeekHerald
Cantor Fitzgerald Analysts Give CymaBay Therapeutics $CBAY a $20.00 Price Target https://t.co/etu2Ir142N
April 14th 2019, 8:04pm
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY Given a $18.00 Price Target by Oppenheimer Analysts https://t.co/X2anRzLVmO
April 14th 2019, 8:04pm
OlympiaReport @OlympiaReport
CymaBay Therapeutics $CBAY Given a $18.00 Price Target by Oppenheimer Analysts https://t.co/t5r7GfU7L7
April 14th 2019, 8:04pm
ThisLincolnian @ThisLincolnian
Cantor Fitzgerald Analysts Give CymaBay Therapeutics $CBAY a $20.00 Price Target https://t.co/gr6xaDiEw0
April 14th 2019, 8:04pm
WeekHerald @WeekHerald
BidaskClub Lowers CymaBay Therapeutics $CBAY to Buy https://t.co/sRPo8qlZcG
April 14th 2019, 11:04am
ConsumerFeed @ConsumerFeed
ValuEngine Lowers CymaBay Therapeutics $CBAY to Buy https://t.co/BejKY0vAUn
April 14th 2019, 11:04am
ThisLincolnian @ThisLincolnian
BidaskClub Lowers CymaBay Therapeutics $CBAY to Buy https://t.co/pEai00SkEP
April 14th 2019, 11:04am
TickerReport @TickerReport
CymaBay Therapeutics Inc $CBAY Given Average Recommendation of “Buy” by Brokerages https://t.co/Zctj6yQFzJ
April 13th 2019, 4:04pm
WatchlistN @WatchlistN
CymaBay Therapeutics Inc $CBAY Receives $19.83 Consensus Target Price from Analysts https://t.co/Hp7NKQ4uiv
April 13th 2019, 4:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.